Global Alopecia Areata Drug Market Targets 2036 Expansion as OX40L Inhibitors Enter Clinical Pipelines
The worldwide alopecia areata treatment market is forecast to expand significantly by 2036, driven by new drug classes including OX40L inhibitors and interleukin-targeting agents.<sup>1</sup> The autoimmune hair-loss condition affects millions across every region, but effective therapies have historically been scarce. Regulatory momentum in Europe, the US, and Asia-Pacific is accelerating as autoimmune drug approvals broaden.
Salvado•